foxo4-dri senolytic peptide human trial 2024 The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI foxo4-dri senolytic peptide human trials
Pay in 4 interest-free payments of $5.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4





























